Shanghai Roche announces Avastin OK in China

Joint venture Shanghai Roche Pharma has announced Chinese approval for cancer treatment Avastin. The announcement follows by a week the news of an Avastin fake used as a treatment for eye disease causing adverse reactions in more than half of those given the knockoff. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.